These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36294308)

  • 1. Post-Implant Phosphodiesterase-5 Inhibitors in Patients with Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.
    Xanthopoulos A; Magouliotis DE; Tryposkiadis K; Zotos PA; Spiliopoulos K; Athanasiou T; Giamouzis G; Skoularigis J; Starling RC; Triposkiadis F
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation.
    Xanthopoulos A; Tryposkiadis K; Triposkiadis F; Fukamachi K; Soltesz EG; Young JB; Wolski K; Blackstone EH; Starling RC
    J Am Heart Assoc; 2020 Jul; 9(14):e015897. PubMed ID: 32648508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postimplant Phosphodiesterase-5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices.
    Xanthopoulos A; Wolski K; Wang Q; Blackstone EH; Randhawa VK; Soltesz EG; Young JB; Nissen SE; Estep JD; Triposkiadis F; Starling RC
    JACC Heart Fail; 2022 Feb; 10(2):89-100. PubMed ID: 35115092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Adverse Events With Phosphodiesterase 5 Inhibitors Post LVAD Implantation: Is It Time for a Randomized Trial?
    Starling RC; Xanthopoulos A; Nissen SE; Triposkiadis F
    J Card Fail; 2022 Dec; 28(12):1733-1737. PubMed ID: 35690316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis.
    Kittipibul V; Blumer V; Angsubhakorn N; Hernandez GA; Chaparro S; Tedford RJ; Agarwal R
    J Card Fail; 2021 Apr; 27(4):477-485. PubMed ID: 33385522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of pump thrombosis and stroke in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding.
    Szymanski TW; Weeks PA; Patel CJ; Jezovnik MK; Gulbis B; Nathan SS; Jumean MF; Radovancevic R; Kar B; Gregoric ID
    Artif Organs; 2020 Nov; 44(11):1171-1175. PubMed ID: 32530086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bleeding risk with phosphodiesterase-5 inhibitors after left ventricular assist device implantation.
    Jakstaite AM; Luedike P; Schmack B; Pizanis N; Riebisch M; Weymann A; Kamler M; Ruhparwar A; Rassaf T; Papathanasiou M
    ESC Heart Fail; 2021 Aug; 8(4):2419-2427. PubMed ID: 33821578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure.
    Triposkiadis F; Xanthopoulos A; Skoularigis J; Starling RC
    Heart Fail Rev; 2022 Nov; 27(6):1991-2003. PubMed ID: 35437713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study.
    Saeed O; Colombo PC; Mehra MR; Uriel N; Goldstein DJ; Cleveland J; Connors JM; Najjar SS; Mokadam NA; Bansal A; Crandall DL; Sood P; Jorde UP
    J Heart Lung Transplant; 2020 Jun; 39(6):518-525. PubMed ID: 32340871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy.
    Malone G; Abdelsayed G; Bligh F; Al Qattan F; Syed S; Varatharajullu P; Msellati A; Mwipatayi D; Azhar M; Malone A; Fatimi SH; Conway C; Hameed A
    J Anat; 2023 Jan; 242(1):29-49. PubMed ID: 35445389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
    Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphodiesterase-5 inhibitors in pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes.
    Turner JM; Russo F; Deprest J; Mol BW; Kumar S
    BJOG; 2022 Oct; 129(11):1817-1831. PubMed ID: 35352868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to Optimize Patient Selection and Device Performance of the Newest Generation Left Ventricular Assist Devices.
    Albert CL; Estep JD
    Curr Treat Options Cardiovasc Med; 2019 Aug; 21(9):48. PubMed ID: 31388835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary outcomes of continuous-flow left ventricular assist devices-a systematic review.
    McNamara N; Narroway H; Williams M; Brookes J; Farag J; Cistulli D; Bannon P; Marasco S; Potapov E; Loforte A
    Ann Cardiothorac Surg; 2021 Mar; 10(2):186-208. PubMed ID: 33842214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex disparities in left ventricular assist device implantation outcomes: A systematic review and meta-analysis of over 50 000 patients.
    Arjomandi Rad A; Kapadia S; Zubarevich A; Nanchahal S; Van den Eynde J; Vardanyan R; Bareka M; Krasopoulos G; Quarto C; Ruhparwar A; Athanasiou T; Weymann A
    Artif Organs; 2023 Feb; 47(2):273-289. PubMed ID: 36461903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients.
    Lopilato AC; Doligalski CT; Caldeira C
    Artif Organs; 2015 Nov; 39(11):939-44. PubMed ID: 25912789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.